Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Clinical trial NCT00275132 · COMPLETED
Trial details
- NCT number
- NCT00275132
- Sponsor
- University College, London
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2009-04-01
- Enrollment
- 670
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.